[One-step real-time fluorescence quantitative PCR for detecting WT1 mRNA expression in leukemia]

Area of Science:

• Molecular Biology
• Oncology
• Diagnostic Assays

Context:

• Leukemia diagnosis and prognosis rely on accurate monitoring of Wilms Tumor 1 (WT1) gene expression.
• Current methods for WT1 mRNA detection can be complex and time-consuming.
• There is a need for a sensitive and reliable assay for minimal residual disease (MRD) detection in leukemia.

Purpose:

• To develop and validate a one-step real-time quantitative reverse transcription polymerase chain reaction (RT-PCR) assay for WT1 mRNA detection.
• To assess the assay's sensitivity, repeatability, and stability for clinical application.
• To enable early detection of MRD and improve prognostic prediction in leukemia patients.

Summary:

• A novel one-step real-time quantitative RT-PCR assay was established using K562 cell-derived RNA, a Taqman-MGB fluorescent probe, and specific primers.
• The assay demonstrated high sensitivity (10^-4 level) and excellent correlation (r=0.998) between Ct values and initial template concentrations.
• Repeatability and inter-assay variability were confirmed with coefficients of variation below 8%.

Impact:

• This assay provides a sensitive, repeatable, and specific method for WT1 mRNA quantification.
• The one-step process simplifies operation and reduces contamination risk, facilitating clinical use.
• Improved MRD detection and prognostic capabilities can lead to more personalized and effective leukemia treatment strategies.